Chris A. Rallis, Director at FENNEC PHARMACEUTICALS INC. (FENC), sold 8,346 shares at $7.04 ($59K) on 2026-05-11, disclosed to the SEC on 2026-05-12.
Scheduled sale ($59k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| FENC | SELL | 2025-04-11 | $7K | — | Filing → |
| FENC | SELL | 2025-02-14 | $8K | — | Filing → |
| FENC | SELL | 2024-12-02 | $39K | — | Filing → |